Brief: Portage Biotech Announces Clinical Trial Collaboration Agreement With Merck
08/11/2022 13:58
Nov 8 (Reuters) - Portage Biotech Inc PRTG.O :
* PORTAGE BIOTECH ANNOUNCES CLINICAL TRIAL COLLABORATION
AGREEMENT
WITH MERCK
* PORTAGE BIOTECH ANNOUNCES CLINICAL TRIAL COLLABORATION
AGREEMENT
WITH MERCK
* PORTAGE BIOTECH INC- MERCK WILL BE PROVIDING KEYTRUDA FOR
PORTAGE BIOTECH'S IMPORT-201 TRIAL
Source text for Eikon: ID:nGNX5Shby5
Further company coverage: PRTG.O
Recent news on Alpha Compute
See all newsBrief: Alpha Compute Corp. Provides Mid-Q2 2026 Update
Brief: Alpha Compute Ai Gpu Launch Update First Large-Scale Nvidia Blackwell Cluster
Brief: Alpha Compute Appoints Tom Richer To Advisory Board To Accelerate Ai Gpu Compute Infrastructure And Confidential Cloud Strategy
Brief: Alphaton Capital Rebrands As Alpha Compute Corp. To Reflect Its Growing Ai Compute Business
Brief: Alphaton Capital Announces $43 Million Ai Infrastructure And Financing Partnership With Vertical Data